title: CD4+FOXP3+ Regulatory T-Cell Subsets in Human Immunodeficiency Virus Infection.
abstract: The role of CD4+FOXP3+ regulatory T cells (Treg) in human immunodeficiency virus (HIV) infection has been an area of intensive investigation and remains a matter of ardent debate. Investigation and interpretation suffered from uncertainties concerning Treg quantification. Firstly, Treg quantification and function in HIV infection remain controversial in part because of the lack of reliable and specific markers to identify human Tregs. Secondly, analyzing Treg percentages or absolute numbers led to apparent discrepancies that are now solved: it is now commonly accepted that Treg are targets of HIV infection, but are preferentially preserved compared to conventional CD4 T cells. Moreover, the duality of immune defects associated to HIV infection, i.e., low grade chronic inflammation and defects in HIV-specific responses also casts doubts on the potential impact of Treg on HIV infection. Tregs may be beneficial or/and detrimental to the control of HIV infection by suppressing chronic inflammation or HIV-specific responses respectively. Indeed both effects of Treg suppression have been described in HIV infection. The discovery in recent years of the existence of phenotypically and functionally distinct human CD4+FOXP3+ Treg subsets may provide a unique opportunity to reconcile these contrasting results. It is tempting to speculate that different Treg subsets exert these different suppressive effects. This review summarizes available data concerning Treg fate during HIV infection when considering Treg globally or as subsets. We discuss how the identification of naïve and effector Treg subsets modulates our understanding of Treg biology during HIV infection and the potential impact of HIV infection on mechanisms governing peripheral differentiation of adaptive Tregs.
authors.affiliation: INSERM, U1012 , Le Kremlin-Bicêtre , France ; Université Paris-SUD, UMR-S1012 , Le Kremlin-Bicêtre , France ; Division of Immunology and Allergy, Department of Internal Medicine, Geneva University Hospitals , Geneva , Switzerland.
authors.forename: Federico
authors.initials: F
authors.lastname: Simonetta
authors.forename: Christine
authors.initials: C
authors.lastname: Bourgeois
keywords: CD25; FOXP3; HIV; Treg
references.citation: Immunity. 2008 Jun;28(6):870-80
references.pmid: 18513999
references.citation: Clin Exp Immunol. 2009 Jan;155(1):44-52
references.pmid: 19016807
references.citation: J Infect Dis. 2012 May 15;205(10):1479-82
references.pmid: 22457283
references.citation: Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10632-7
references.pmid: 20498045
references.citation: J Immunol. 2005 Apr 1;174(7):4407-14
references.pmid: 15778406
references.citation: J Immunol. 2013 Mar 1;190(5):2001-8
references.pmid: 23359504
references.citation: J Exp Med. 2012 Sep 24;209(10):1713-22, S1-19
references.pmid: 22966003
references.citation: PLoS One. 2012;7(1):e30307
references.pmid: 22276176
references.citation: PLoS One. 2012;7(12):e52580
references.pmid: 23285102
references.citation: Blood. 2007 Aug 15;110(4):1225-32
references.pmid: 17449799
references.citation: Nat Immunol. 2003 Apr;4(4):337-42
references.pmid: 12612581
references.citation: PLoS Pathog. 2011 Jul;7(7):e1002110
references.pmid: 21750674
references.citation: J Exp Med. 2007 Jun 11;204(6):1257-65
references.pmid: 17502665
references.citation: Blood. 2004 Nov 15;104(10):3249-56
references.pmid: 15271794
references.citation: Neuro Oncol. 2011 Dec;13(12):1308-23
references.pmid: 21908444
references.citation: Eur J Immunol. 2005 Nov;35(11):3332-42
references.pmid: 16231285
references.citation: Science. 2003 Feb 14;299(5609):1057-61
references.pmid: 12522256
references.citation: J Infect Dis. 2006 Feb 15;193(4):494-504
references.pmid: 16425128
references.citation: J Virol. 2008 Sep;82(17):8307-15
references.pmid: 18579608
references.citation: AIDS. 2008 Nov 30;22(18):2451-60
references.pmid: 19005268
references.citation: J Virol. 2009 Dec;83(24):12925-33
references.pmid: 19828616
references.citation: J Exp Med. 2006 Jul 10;203(7):1693-700
references.pmid: 16818676
references.citation: Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):14122-7
references.pmid: 22879398
references.citation: PLoS One. 2010 Jul 21;5(7):e11659
references.pmid: 20657770
references.citation: Sci Transl Med. 2010 May 19;2(32):32ra36
references.pmid: 20484731
references.citation: PLoS One. 2011 Jan 31;6(1):e15924
references.pmid: 21305005
references.citation: AIDS. 2010 Feb 20;24(4):491-502
references.pmid: 20071976
references.citation: Eur J Immunol. 2008 Apr;38(4):918-21
references.pmid: 18395860
references.citation: J Clin Invest. 2005 Jul;115(7):1953-62
references.pmid: 16007258
references.citation: PLoS One. 2012;7(3):e34547
references.pmid: 22479644
references.citation: Blood. 2004 Aug 15;104(4):942-7
references.pmid: 15117761
references.citation: J Exp Med. 2001 Jun 4;193(11):1295-302
references.pmid: 11390436
references.citation: AIDS. 2010 Aug 24;24(13):1991-2000
references.pmid: 20651586
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3390-5
references.pmid: 17360656
references.citation: Clin Exp Immunol. 2009 Jan;155(1):35-43
references.pmid: 19076827
references.citation: PLoS One. 2011;6(12):e28118
references.pmid: 22162758
references.citation: Clin Exp Immunol. 2008 Oct;154(1):80-6
references.pmid: 18821942
references.citation: AIDS. 2007 Jul 31;21(12):1525-34
references.pmid: 17630546
references.citation: AIDS Res Hum Retroviruses. 2012 Apr;28(4):339-45
references.pmid: 21767239
references.citation: Blood. 2010 Apr 15;115(15):e20-32
references.pmid: 20160163
references.citation: J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):577-80
references.pmid: 18645514
references.citation: J Exp Med. 2004 Aug 2;200(3):331-43
references.pmid: 15280419
references.citation: PLoS One. 2006 Dec 20;1:e102
references.pmid: 17183635
references.citation: Nat Immunol. 2003 Apr;4(4):330-6
references.pmid: 12612578
references.citation: PLoS One. 2011;6(8):e24226
references.pmid: 21918685
references.citation: Nat Rev Immunol. 2010 Jul;10(7):490-500
references.pmid: 20559327
references.citation: J Infect Dis. 2010 Aug 15;202(3):362-9
references.pmid: 20560766
references.citation: Annu Rev Immunol. 2009;27:551-89
references.pmid: 19302048
references.citation: Blood. 2006 Nov 1;108(9):3072-8
references.pmid: 16728694
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13439-44
references.pmid: 19666573
references.citation: Blood. 2011 May 19;117(20):5372-80
references.pmid: 21436067
references.citation: Blood. 2013 Jan 3;121(1):29-37
references.pmid: 23043072
references.citation: J Clin Invest. 2008 Oct;118(10):3431-9
references.pmid: 18776940
references.citation: Blood. 2006 Dec 1;108(12):3808-17
references.pmid: 16902147
references.citation: PLoS Biol. 2004 Jul;2(7):E198
references.pmid: 15252446
references.citation: N Engl J Med. 2009 Oct 15;361(16):1548-59
references.pmid: 19828532
references.citation: J Virol. 2011 Feb;85(3):1287-97
references.pmid: 21047964
references.citation: PLoS One. 2010 Feb 17;5(2):e9254
references.pmid: 20174666
references.citation: Nat Med. 2011 Jul 17;17(8):989-95
references.pmid: 21765403
references.citation: AIDS Res Hum Retroviruses. 2012 Sep;28(9):1044-51
references.pmid: 22214236
references.citation: J Acquir Immune Defic Syndr. 2010 Aug;54(5):455-62
references.pmid: 20585263
references.citation: AIDS Res Hum Retroviruses. 2009 Feb;25(2):183-91
references.pmid: 19239357
references.citation: J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):248-57
references.pmid: 19363449
references.citation: J Immunol. 2012 Feb 1;188(3):976-80
references.pmid: 22198953
references.citation: Clin Immunol. 2011 Sep;140(3):218-22
references.pmid: 21570917
references.citation: Immunol Cell Biol. 2006 Dec;84(6):530-6
references.pmid: 16956389
references.citation: J Leukoc Biol. 2008 Feb;83(2):254-62
references.pmid: 17982112
references.citation: J Infect Dis. 2011 Feb 15;203(4):496-9
references.pmid: 21177309
references.citation: J Virol. 2004 Mar;78(5):2454-9
references.pmid: 14963140
references.citation: J Immunol. 2006 Apr 15;176(8):4622-31
references.pmid: 16585553
references.citation: Clin Infect Dis. 2005 Oct 1;41(7):1053-6
references.pmid: 16142675
references.citation: AIDS. 2006 Aug 1;20(12):1669-71
references.pmid: 16868450
references.citation: Blood. 2006 Nov 15;108(10):3371-8
references.pmid: 16868256
references.citation: J Infect Dis. 2012 May 15;205(10):1510-9
references.pmid: 22457280
references.citation: AIDS. 2005 Jun 10;19(9):879-86
references.pmid: 15905668
references.citation: J Exp Med. 2012 Sep 24;209(10):1723-42, S1
references.pmid: 22966001
references.citation: J Virol. 2011 Nov;85(21):11422-34
references.pmid: 21880771
references.citation: AIDS. 2013 Apr 24;27(7):1059-69
references.pmid: 23299175
references.citation: Immunology. 2009 Sep;128(1 Suppl):e366-75
references.pmid: 19016904
references.citation: J Immunol. 2010 Dec 15;185(12):7129; author reply 7130
references.pmid: 21127313
references.citation: Blood. 2006 Apr 1;107(7):2830-8
references.pmid: 16332974
references.citation: AIDS. 2012 Jan 14;26(2):139-48
references.pmid: 22045342
references.citation: AIDS Res Hum Retroviruses. 1996 Jan 1;12(1):17-24
references.pmid: 8825614
references.citation: AIDS. 2006 Oct 24;20(16):2033-41
references.pmid: 17053349
references.citation: J Exp Med. 2001 Jun 4;193(11):1303-10
references.pmid: 11390437
references.citation: Chin Med J (Engl). 2011 Aug;124(15):2340-6
references.pmid: 21933566
references.citation: PLoS One. 2008 Oct 01;3(10):e3305
references.pmid: 18827929
references.citation: J Immunol. 2009 Oct 15;183(8):4843-7
references.pmid: 19801510
references.citation: J Virol. 2007 Nov;81(21):11593-603
references.pmid: 17715231
references.citation: Int Immunol. 2007 Apr;19(4):345-54
references.pmid: 17329235
references.citation: PLoS One. 2008 Jul 16;3(7):e2705
references.pmid: 18628982
references.citation: Eur J Immunol. 2009 Jan;39(1):301-9
references.pmid: 19089812
references.citation: J Immunol. 2008 Jan 15;180(2):764-73
references.pmid: 18178814
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13445-50
references.pmid: 19651619
references.citation: J Immunol. 1995 Aug 1;155(3):1151-64
references.pmid: 7636184
references.citation: Clin Immunol. 2009 Mar;130(3):298-303
references.pmid: 19008157
references.citation: J Exp Med. 2006 Jul 10;203(7):1701-11
references.pmid: 16818678
references.citation: AIDS. 2010 May 15;24(8):1095-105
references.pmid: 20400885
references.citation: J Immunol. 2010 Apr 1;184(7):3433-41
references.pmid: 20181882
references.citation: J Immunol. 2001 Aug 1;167(3):1245-53
references.pmid: 11466340
references.citation: Jpn J Infect Dis. 2008 Sep;61(5):391-2
references.pmid: 18806350
references.citation: Immunology. 2008 Jan;123(1):129-38
references.pmid: 18028372
references.citation: J Exp Med. 2001 Jun 4;193(11):1285-94
references.pmid: 11390435
references.citation: J Infect Dis. 2012 May 15;205(10):1495-500
references.pmid: 22427677
references.citation: J Infect Dis. 2012 May 15;205(10):1501-9
references.pmid: 22457273
references.citation: J Acquir Immune Defic Syndr. 2011 Jun 1;57(2):101-8
references.pmid: 21407087
references.citation: Blood. 2001 Nov 1;98(9):2736-44
references.pmid: 11675346
references.citation: Eur J Immunol. 2009 Jun;39(6):1466-71
references.pmid: 19499532
references.citation: J Clin Invest. 2006 Sep;116(9):2423-33
references.pmid: 16955142
references.citation: PLoS One. 2012;7(8):e42802
references.pmid: 22912740
references.citation: Immunity. 2009 Jun 19;30(6):899-911
references.pmid: 19464196